Low-dose intermittent alemtuzumab in the treatment of Sezary syndrome: clinical and immunologic findings in 14 patients
Bernengo, M. G., Quaglino, P., Comessatti, A., Ortoncelli, M., Novelli, M., Lisa, F., Fierro, M. T.Volume:
92
Language:
english
Journal:
Haematologica
DOI:
10.3324/haematol.11127
Date:
June, 2007
File:
PDF, 39.95 MB
english, 2007